Gainers
- OTR Acquisition Corp. (NASDAQ:OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.
- Calithera Biosciences, Inc. (NASDAQ:CALA) rose 46.3% to $0.2358 in pre-market trading. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
- Affirm Holdings, Inc. (NASDAQ:AFRM) shares rose 31.2% to $23.66 in pre-market trading after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
- Molecular Partners AG (NASDAQ:MOLN) rose 28.2% to $7.79 in pre-market trading. Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 22.5% to $0.1630 in pre-market trading after jumping over 70% on Thursday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
- Robinhood Markets, Inc. (NASDAQ:HOOD) shares rose 22% to $10.46 in pre-market trading after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
- Landos Biopharma, Inc. (NASDAQ:LABP) rose 19% to $0.7959 in pre-market trading after the company said Q1 EPS results were higher year over year.
- Duolingo, Inc. (NASDAQ:DUOL) rose 17.6% to $78.81 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
- Molecular Data Inc. (NASDAQ:MKD) rose 14.6% to $0.1044 in pre-market trading after jumping around 17% on Thursday.
- SciSparc Ltd. (NASDAQ:SPRC) rose 13.4% to $3.29 in pre-market trading after jumping 23% on Thursday.
- KULR Technology Group, Inc. (NASDAQ:KULR) rose 13.1% to $1.38 in pre-market trading after dropping 4% on Thursday.
- McEwen Mining Inc. (NYSE:MUX) rose 12.1% to $0.5167 in pre-market trading. McEwen Mining recently posted a Q1 loss of $0.04 per share.
- Redwire Corporation (NYSE:RDW) rose 10.8% to $4.10 in pre-market trading following Q1 results.
- Fangdd Network Group Ltd. (NASDAQ:DUO) rose 9.3% to $0.2352 in pre-market trading after gaining around 8% on Thursday.
- The RealReal, Inc. (NASDAQ:REAL) rose 9.3% to $3.52 in pre-market trading after dipping around 6% on Thursday.
Don’t forget to check out our premarket coverage here .
Losers
- LiqTech International, Inc. (NASDAQ:LIQT) shares fell 48.6% to $0.47 in pre-market trading after the company priced its public offering of common stock and pre-funded warrants.
- FIGS, Inc. (NYSE:FIGS) shares fell 25.1% to $9.62 in pre-market trading after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 14.4% to $0.19 in pre-market trading. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
- Twitter, Inc. (NYSE:TWTR) fell 14.2% to $38.70 in pre-market trading. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 9.5% to $0.2262 in pre-market trading. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
- Dakota Gold Corp. (NYSE:DC) fell 9.3% to $2.90 in pre-market trading after dipping 6% on Thursday.
- Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 8.4% to $0.2250 in pre-market trading. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
- Sky Harbour Group Corporation (NYSE:SKYH) fell 6.7% to $8.05 in pre-market trading after reporting Q1 results.
